Literature DB >> 12173106

Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar media.

D E Roe1, S M Finegold, D M Citron, E J C Goldstein, H M Wexler, J E Rosenblatt, M E Cox, S G Jenkins, D W Hecht.   

Abstract

A multilaboratory study compared the growth of 30 fastidious anaerobes, using 5 different agar media: Wilkins-Chalgren (WC), WC with either whole or laked sheep blood, and Brucella supplemented with vitamin K(1) and hemin and either laked or whole sheep blood. The media were compared for quality and quantity of growth. Experiments were conducted either entirely in an anaerobic chamber or inoculated in ambient air with anaerobic incubation. The results showed that (1) any medium plus whole or laked blood was better than unsupplemented WC, (2) whole blood and laked blood additives gave similar results, (3) supplemented Brucella with whole or laked blood was superior to WC and WC with whole or laked blood, and (4) anaerobic and aerobic inoculation with anaerobic incubation gave similar results. Brucella agar supplemented with whole or laked blood supports the growth of fastidious anaerobic species better than the WC agars do.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173106     DOI: 10.1086/341918

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.

Authors:  Lin Lü; Han-qing Zeng; Pi-long Wang; Wei Shen; Ting-xiu Xiang; Zhe-chuan Mei
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

2.  Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010.

Authors:  Piyada Wangroongsarb; Tomoko Kohda; Chutima Jittaprasartsin; Karun Suthivarakom; Thanitchi Kamthalang; Kaoru Umeda; Pathom Sawanpanyalert; Shunji Kozaki; Kazuyoshi Ikuta
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.